Predictors of Survival in HIV-Infected Patient after Initiation of HAART in Zewditu Memorial Hospital, Addis Ababa, Ethiopia
Table 2
Cox regression analysis by clinical, laboratory, substance use, and ART characteristics information of patients who started HHART in Zewditu Memorial Hospital, September 2008–February 2012 ().
Variables
Alive
Dead
CHR (95% CI)
value
AHR (95% CI)
WHO stage
1-2
183
7
1.0
1.0
3-4
196
30
3.89 (1.71, 8.86)*
0.001
2.99 (1.26, 5.31)*
Hemoglobin in gm/dL
<10
31
9
6.55 (3.27, 13.12)*
0.001
5.54 (2.58, 11.86)*
≥10
285
24
1.0
1.0
CD4 count cells/µL
<50
54
9
0.52 (0.24, 1.11)
0.09
0.77 (0.33, 1.83)
≥50
306
24
1.0
1.0
BMI in kg/m2
<18.5
26
2
1.13 (0.23, 5.43)
0.882
≥18.5
108
7
1.0
Past TB treatment
No
337
28
1.0
1.0
Yes
38
9
2.90 (1.36, 6.17)*
0.006
4.13 (1.79, 9.51)*
Tobacco use
Nonuser
293
22
1.0
—
User
81
15
0.85 (0.37, 1.93)
0.691
Soft drug (kchat, shisha) use
Nonuser
252
26
1.0
—
User
126
11
0.82 (0.41, 1.67)
0.586
Hard drug (iv drug,…) use
Nonuser
342
36
1.0
0.235
1.0
User
33
1
0.30 (0.04, 2.19)
0.73 (0.09, 5.65)
A cox proportional hazards model adjusted for all variables listed in the table. HR: hazard ratio; CI: confidence interval; ART: antiretroviral therapy; WHO: World Health Organization; BMI: body mass index.
*indicates that the variables significantly associated with the outcome at 95% level of significant ().
